Article
Biochemistry & Molecular Biology
Wen Peng, Shuang Shi, Jiacheng Zhong, Hanghua Liang, Jianbin Hou, Xiaosong Hu, Feng Wang, Jiayi Zhang, Shengjun Geng, Xiaochuan Sun, Dong Zhong, Hongjuan Cui
Summary: CBX3, also known as HP1 gamma, is upregulated in glioblastoma multiforme (GBM) and promotes cell proliferation, invasion, and tumorigenesis. It regulates the malignant progression of GBM through an EGFR-dependent mechanism. CBX3 directly suppresses the transcriptional levels of PARK2 and STUB1, reducing the ubiquitination of EGFR.
Article
Biochemistry & Molecular Biology
Fang Zhang, Yong Li, Lipeng Gan, Xiaomei Tong, Dandan Qi, Qihui Wang, Xin Ye
Summary: The study identified lncRNA MAFG-AS1 as upregulated in HBV-related HCC tissues, leading to enhanced proliferation and migration of HCC cells, suggesting its potential oncogenic role in HBV-related HCC development.
Article
Oncology
Min Hou, Nannan Wu, Lili Yao
Summary: A novel functional lncRNA CBR3-AS1 was identified to promote nuclear localization of beta-catenin, facilitating the activation of Wnt/beta-catenin signaling and regulating the proliferation, migration, and invasion of LAD cells.
CANCER CELL INTERNATIONAL
(2021)
Article
Oncology
Weitao Yao, Jingyu Hou, Guoqing Liu, Fangxing Wu, Qiang Yan, Liangyu Guo, Chuchu Wang
Summary: The study found that CBR3-AS1 is highly expressed in osteosarcoma cells and promotes the stemness and EMT of these cells, as well as tumor growth.
MOLECULAR THERAPY-ONCOLYTICS
(2022)
Article
Medicine, General & Internal
Yanjiao Ou, Yong Deng, Hong Wang, Qingyi Zhang, Huan Luo, Peng Hu
Summary: This study identified a novel lncRNA PRKAG2-AS1 as a potential therapeutic target in hepatocellular carcinoma, demonstrating its association with clinical implications and malignant behaviors. PRKAG2-AS1 may function through regulating the miR-502-3p/BICD2 axis.
FRONTIERS IN MEDICINE
(2021)
Article
Cell Biology
Wenyang Zhou, Yuying Hu, Baosheng Wang, Lina Yuan, Jia Ma, Xiangpeng Meng
Summary: The study reveals that PELI1 is highly expressed in pancreatic cancer and is associated with poor prognosis in patients. PELI1 promotes cell proliferation, migration, and invasion, while inhibiting apoptosis in pancreatic cancer. Xenograft tumor experiments confirm the role of PELI1 in promoting tumor growth.
CELLULAR SIGNALLING
(2023)
Article
Biotechnology & Applied Microbiology
Yuxiao Zheng, Feng Qi, Lu Li, Bin Yu, Yifei Cheng, Minghui Ge, Chao Qin, Xiao Li
Summary: This study identified lncNAP1L6 as an oncogene in prostate cancer (PCa) and suggested it as a potential therapeutic target. Functional assays revealed that lncNAP1L6 promotes cell migration, invasion, and epithelial-mesenchymal transition (EMT) in PCa. Mechanism assays showed that lncNAP1L6 regulates NAP1L2 mRNA stability through METTL14/METTL3 complex-mediated m6A methylation and interacts with YY1 to activate MMP signaling pathway.
CANCER GENE THERAPY
(2023)
Article
Pathology
Li Zhang, Qingfeng Wan, Huiyun Zhou
Summary: This study elucidated the molecular mechanism of LOXL1-AS1 in trophoblast cell proliferation and migration, showing that it can target miR-515-5p and NF-kappa B signaling pathways. The results suggest that LOXL1-AS1 may serve as a potential therapeutic target in cancer treatment.
EXPERIMENTAL AND MOLECULAR PATHOLOGY
(2021)
Article
Oncology
Xinping Chen, Weihua Xu, Zhichao Ma, Juan Zhu, Junjie Hu, Xiaojuan Li, Shengmiao Fu
Summary: This study focused on the involvement of TTN-AS1 in nasopharyngeal carcinoma (NPC) and its impact on the progression of NPC. The results showed that TTN-AS1 was highly expressed in NPC cells and its depletion inhibited cell proliferation, migration, and invasion while stimulating apoptosis. TTN-AS1 was found to interact with miR-876-5p and UPF1, enhancing the expression of NETO2. Additionally, TTN-AS1 could be transcriptionally activated by YY1 in NPC cells. These findings provide valuable insights into the development of effective treatments for NPC.
MOLECULAR THERAPY-ONCOLYTICS
(2022)
Article
Multidisciplinary Sciences
Jin-Ze Tian, Sheng Xing, Jing-Yi Feng, Shu-Hua Yang, Yan-Fu Ding, Xue-Ting Huang, Jin-Shu Yang, Wei-Jun Yang
Summary: Studies have revealed the presence of a small population of SETD4(+) cells in the adult mouse pancreas, which play critical roles in pancreatic development, homeostasis, and response to injury. These cells are essential for the regeneration of acinar cells, and their ablation can affect the regeneration process.
SCIENTIFIC REPORTS
(2021)
Article
Biochemistry & Molecular Biology
Roland Abi Nahed, Maya Elkhoury Mikhael, Deborah Reynaud, Constance Collet, Nicolas Lemaitre, Thierry Michy, Pascale Hoffmann, Frederic Sergent, Christel Marquette, Padma Murthi, Tiphaine Raia-Barjat, Nadia Alfaidy, Mohamed Benharouga
Summary: NLRP7 gene is overexpressed in gestational choriocarcinoma (CC) and may contribute to cancer cells' tolerance to the maternal immune system through regulating immune tolerance-related factors and promoting cell proliferation while inhibiting differentiation.
Article
Oncology
Qibin Wu, Meilian Peng, Chengyu Lv, Lihua Chen, Xiaodan Mao, Tianfu Lin, Pengming Sun, Yifeng Wang
Summary: This study aimed to investigate the role and prognostic value of Claudin-6 (CLDN6) in gestational trophoblastic disease (GTD). The results showed that CLDN6 was highly expressed in GTD and was correlated with certain clinical-pathological parameters. Furthermore, silencing CLDN6 could inhibit proliferation and migration of choriocarcinoma (CC) cells. The study suggests that CLDN6 may serve as a new therapeutic target for CC.
CLINICAL & TRANSLATIONAL ONCOLOGY
(2023)
Article
Multidisciplinary Sciences
Haoran Zhang, Wenqiu Wang, Junjie Lin, Junbo Qiao, Xinjun Wang, Bin Fang, Changkuan Chen, Yujiao Wang, Gaozan Zhu, Wenbo Liu
Summary: In this study, it was found that lncRNA LEF1-AS1 was upregulated in venous malformations. By competitively binding to miR-489-3p, LEF1-AS1 promoted the expression of S100A11, thereby enhancing the proliferation, migration, and angiogenesis of HUVEC cells.
Article
Oncology
Haihua Jiang, Qinglong He, Tingyan Liu
Summary: The study revealed that high expression of BBOX1-AS1 was detected in nasopharyngeal carcinoma tissues, and its silencing significantly suppressed the proliferative, migratory, and invasive abilities in NPC cells. BBOX1-AS1 specifically bound to miR-3940-3 and abrogated the inhibition of KPNA2 induced by miR-3940-3.
CANCER MANAGEMENT AND RESEARCH
(2021)
Article
Medicine, Research & Experimental
Zheyu Hu, Yixian Liu, Jin Tang, Jiajia Qin, Zexun Mo, Jianjiang Xie, Xuan Jiang, Shuquan Wei, Chuwen Lin
Summary: This study uncovers the role of HHIP-AS1 as a novel tumor suppressor in lung squamous cell carcinoma (LUSC) and provides new insights into the molecular regulation of LUSC, which will help in the development of new therapeutic strategies.